paclitaxel has been researched along with Teratocarcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brozmanová, K; Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Risnyovzská, Z; Sálek, T; Svetlovská, D; Sycová-Milá, Z | 1 |
| Bajorin, DF; Bosl, GJ; Chou, TC; Hutter, H; Motzer, RJ; Schwartz, L | 1 |
| Bosl, GJ; Chou, TC; Motzer, RJ; Tong, Y | 1 |
| El-Diery, WS; Wu, GS | 1 |
| Page, M; Paradis, R | 1 |
| Bishop, WR; Chen, J; Ferrari, E; Gurnani, M; Hajian, G; Lipari, P; Liu, M; Malkowski, M; Nielsen, LL; Shi, B; Yaremko, B | 1 |
1 review(s) available for paclitaxel and Teratocarcinoma
| Article | Year |
|---|---|
Paclitaxel in germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Female; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Paclitaxel; Teratocarcinoma; Tumor Cells, Cultured | 1995 |
1 trial(s) available for paclitaxel and Teratocarcinoma
| Article | Year |
|---|---|
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Teratocarcinoma; Testicular Neoplasms | 2007 |
4 other study(ies) available for paclitaxel and Teratocarcinoma
| Article | Year |
|---|---|
Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Antagonism; Drug Synergism; Etoposide; Humans; Paclitaxel; Teratocarcinoma; Topotecan; Tumor Cells, Cultured; Vincristine | 1994 |
p53 and chemosensitivity.
Topics: Animals; Drug Resistance; Female; Genes, p53; Humans; Ovarian Neoplasms; Paclitaxel; Teratocarcinoma; Tumor Cells, Cultured | 1996 |
New active paclitaxel glucuronide derivative with improved water solubility.
Topics: Antineoplastic Agents, Phytogenic; Female; Glucuronides; Humans; Ovarian Neoplasms; Paclitaxel; Solubility; Spectrophotometry, Atomic; Taxoids; Teratocarcinoma; Tumor Cells, Cultured | 1998 |
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.
Topics: Adenocarcinoma; Adenoviruses, Human; Alkyl and Aryl Transferases; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Drug Synergism; Female; Genes, ras; Humans; Male; Mice; Mice, Nude; Mice, SCID; Mice, Transgenic; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Piperidines; Prostatic Neoplasms; Pyridines; Teratocarcinoma; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |